2009
FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
MATSUSHITA, Takehiko; William WILCOX; Chan YUK YU; Aya KAWANAMI; Hülya BÜKÜLMEZ et al.Základní údaje
Originální název
FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
Autoři
MATSUSHITA, Takehiko; William WILCOX; Chan YUK YU; Aya KAWANAMI; Hülya BÜKÜLMEZ; Gener BALMES; Pavel KREJČÍ; Pertchoui B MEKIKIAN; Kazuyuki OTANI; Isakichi YAMAURA; Matthew L. WARMAN; David GIVOL a Shunichi MURAKAMI
Vydání
Human Molecular Genetics, 2009, 0964-6906
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
Genetika a molekulární biologie
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 7.386
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14310/09:00039941
Organizační jednotka
Přírodovědecká fakulta
UT WoS
Klíčová slova anglicky
FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3; TRANSGENIC MICE; CRE RECOMBINASE; BONE-FORMATION; CHONDROCYTE PROLIFERATION; THANATOPHORIC DYSPLASIA; TARGETED DISRUPTION; ACHONDROPLASIA; EXPRESSION
Změněno: 9. 4. 2010 13:50, doc. RNDr. Martin Vácha, Ph.D.
Anotace
V originále
Activating mutations in FGFR3 cause achondroplasia and thanatophoric dysplasia, the most common human skeletal dysplasias. In these disorders, spinal canal and foramen magnum stenosis can cause serious neurologic complications. Here, we provide evidence that FGFR3 and MAPK signaling in chondrocytes promote synchondrosis closure and fusion of ossification centers. We observed premature synchondrosis closure in the spine and cranial base in human cases of homozygous achondroplasia and thanatophoric dysplasia as well as in mouse models of achondroplasia. In both species, premature synchondrosis closure was associated with increased bone formation. Chondrocyte-specific activation of Fgfr3 in mice induced premature synchondrosis closure and enhanced osteoblast differentiation around synchondroses. FGF signaling in chondrocytes increases Bmp ligand mRNA expression and decreases Bmp antagonist mRNA expression in a MAPK-dependent manner, suggesting a role for Bmp signaling in the increased bone formation. The enhanced bone formation would accelerate the fusion of ossification centers and limit the endochondral bone growth. Spinal canal and foramen magnum stenosis in heterozygous achondroplasia patients, therefore, may occur through premature synchondrosis closure. If this is the case, then any growth-promoting treatment for these complications of achondroplasia must precede the timing of the synchondrosis closure.